Susquehanna International Group’s Repare Therapeutics RPTX Stock Holding History

Susquehanna International Group’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,200	Closed	-$55.1K	–	13976
2025 Q4	$55.1K	Buy	+21,200	New	+$42.7K	﹤0.01%	11721
2024 Q3	–	Sell	-16,300	Closed	-$53.8K	–	12885
2024 Q2	$53.8K	Buy	+16,300	New	+$58.1K	﹤0.01%	11378
2023 Q4	–	Sell	-21,300	Closed	-$257K	–	13174
2023 Q3	$257K	Buy	+21,300	New	+$220K	﹤0.01%	9686
2022 Q1	–	Sell	-10,300	Closed	-$217K	–	13838
2021 Q4	$217K	Sell	10,300 -1,600	-13%	-$37.7K	﹤0.01%	11270
2021 Q3	$312K	Buy	11,900 +3,300	+38%	+$107K	﹤0.01%	10516
2021 Q2	$268K	Buy	+8,600	New	+$282K	﹤0.01%	11021

Susquehanna International Group's RPTX Position: Q2 2025 in Review

Susquehanna International Group sold out of Repare Therapeutics (RPTX) in Q2 2025, closing a stake of 40,096 shares — an estimated $52.3K sold.

Susquehanna International Group first reported a position in RPTX in Q4 2020 and held it in 9 quarters. The position peaked at $569K in Q3 2023. 50 funds tracked by Wall St. Rank hold RPTX as of Q2 2025.

Susquehanna International Group reported no remaining Repare Therapeutics position as of Q2 2025 after selling out during the quarter.
Susquehanna International Group sold 40,096 Repare Therapeutics shares in Q2 2025, an estimated $52.3K.
Susquehanna International Group first reported a position in Repare Therapeutics in Q4 2020 and held it in 9 quarters.
Susquehanna International Group's Repare Therapeutics position peaked at $569K in Q3 2023.
50 funds tracked by Wall St. Rank held Repare Therapeutics as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.